The programs must be hospitalwide and adhere to nationally recognized guidelines on the surveillance and prevention of healthcare-associated infections, along with the optimization of antibiotic use.
Hospitals will have six months to implement a program after the final rule is published in the Federal Register.
“The changes are aimed at effectively reducing the development and transmission of HAIs and antibiotic-resistant organisms that ultimately will greatly improve the care and safety of patients while adding cost benefits for hospitals,” CMS said in a fact sheet.
More articles on infection control:
43 Minnesota hospitals recognized for high employee flu shot rates
Connecticut reports first EEE death since 2013
CDC: Deer can spread tuberculosis to humans
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.